The Effect of Periarticular Injection of Methylprednisolone Acetate in Patients with Primary Osteoarthritis of the Proximal Interphalangeal Joints: A Case Controlled Study
Table 2
VAS score at different time points among group 1 and group 2 patients.
G r o u p 1
G r o u p 2
Patient
VAS at baseline
VAS at W1
VAS at W4
VAS at W10
Patient
VAS at baseline
VAS at W1
VAS at W4
VAS at W10
1
55
22
18
51
1
68
24
56
72
2
58
13
19
61
2
47
56
62
66
3
61
5
NA
75
3
65
42
48
48
4
72
15
16
22
4
87
35
66
82
5
76
31
25
43
5
92
42
90
86
6
66
11
38
44
6
95
56
88
76
7
88
9
16
65
7
56
65
63
68
8
64
NA
48
72
8
57
68
NA
88
9
71
8
NA
21
9
84
22
75
76
10
65
44
39
51
10
74
10
88
NA
11
68
27
62
54
11
46
56
67
72
12
56
18
15
NA
12
56
42
22
40
13
64
42
39
59
13
65
34
NA
56
14
71
32
24
66
14
68
22
82
NA
15
85
24
43
52
15
47
56
62
74
16
53
NA
34
67
16
82
92
65
62
17
65
24
74
NA
18
74
10
NA
80
Mean VAS
67
23
29
55
68
45
67
69
P value
0.001
0.001
0.043
0.005
0.534
0.698
Compared to baseline in the same group. VAS=visual analogue scale, W1=1 week following the periarticular injection, W4= 4 weeks following the periarticular injection, W10=10 weeks following the periarticular injection, and NA=not available.